Keith H Crawford

Title: Innovations of Keith H. Crawford in Vitamin D Treatment

Introduction

Keith H. Crawford, a notable inventor located in Lone Tree, Colorado, has made significant contributions to the field of vitamin D treatment. With an impressive portfolio of 21 patents, Crawford's work focuses on creating effective methods and compositions for treating vitamin D insufficiency and deficiency. His innovations have broad implications for improving patient health and managing related conditions.

Latest Patents

Crawford's latest patents include groundbreaking methods for treating vitamin D insufficiency and deficiency. One such patent describes the oral administration of a delayed, sustained release formulation of 25-hydroxyvitamin D. This method can involve administering a sterile intravenous formulation as well. Additionally, his patent encompasses methods for treating and preventing secondary hyperparathyroidism by maintaining proper levels of both 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in patients. These methods aim to ensure that blood concentrations remain within optimal ranges while minimizing the risks associated with hypercalcemia and hyperphosphatemia.

Career Highlights

Crawford's career has led him to work with reputable companies such as Opko Renal and Opko Ireland Global Holdings. His work has significantly contributed to advancing medical treatments through innovative formulations and therapeutic strategies aimed at resolving vitamin D-related health issues.

Collaborations

Throughout his career, Crawford has collaborated with well-regarded professionals in the field, including Charles W. Bishop and Eric J. Messner. These collaborations have fostered a collective effort to enhance research and clinical applications in vitamin D treatment.

Conclusion

Keith H. Crawford's innovations have paved the way for new methods in addressing vitamin D insufficiency and deficiency. His extensive patent portfolio reflects a dedication to advancing medical science and improving health outcomes for patients, showcasing the importance of innovative thinking in the field of healthcare. Crawford’s work is a prime example of how targeted inventions can lead to significant advancements in treatment methodologies.